Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Twist Bioscience (TWST) reported a Q4 loss of $0.59 per share, which was better than the Zacks Consensus Estimate of a $0.73 loss. This is an improvement from the $0.81 loss per share reported a year ago.
November 18, 2024 | 2:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Twist Bioscience reported a Q4 loss of $0.59 per share, better than the expected $0.73 loss, and an improvement from last year's $0.81 loss.
The better-than-expected earnings report, with a smaller loss than anticipated, is likely to positively impact TWST's stock price in the short term. The improvement from the previous year's loss also suggests positive momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100